Cellectis S.A. - ADR earnings per share and revenue
On 07 de nov. de 2025, CLLS reported earnings of 0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.28 USD, resulting in a 103.50% surprise. Revenue reached 37.16 milhão, compared to an expected 7.11 milhão, with a 422.92% difference. The market reacted with a +11.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analistas forecast an EPS of -0.36 USD, with revenue projected to reach 7.70 milhão USD, implying an diminuir of -3700.00% EPS, and diminuir of -79.29% in Revenue from the last quarter.
FAQ
What were Cellectis S.A. - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Cellectis S.A. - ADR reported EPS of $0.01, beating estimates by 103.5%, and revenue of $37.16M, 422.92% above expectations.
How did the market react to Cellectis S.A. - ADR's Q3 2025 earnings?
The stock price moved up 11.29%, changed from $3.19 before the earnings release to $3.55 the day after.
When is Cellectis S.A. - ADR expected to report next?
The next earning report is scheduled for 11 de mar. de 2026.
What are the forecasts for Cellectis S.A. - ADR's next earnings report?
Based on 6
analistas, Cellectis S.A. - ADR is expected to report EPS of -$0.36 and revenue of $7.70M for Q4 2025.